ANHEART
Dead / Abandoned — Abandoned — no statement of use filed (as of 01 Sept 2025)
What this means for you
This application is over — abandoned 01 Sept 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97231152
- Mark type
- Design + words
- Filed
- 21 Jan 2022
- Published for opposition
- 06 Dec 2022
- Abandoned
- 01 Sept 2025
- Attorney of record
- Jenifer deWolf Paine
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer
Owner
- ANHEART THERAPEUTICS LLC, NEW YORK, NY, US
- AnHeart Therapeutics Inc., New York, NY, US
- AnHeart Therapeutics Inc., New York, NY, US
Prosecution history
- 01 Sept 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 01 Sept 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 26 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Apr 2025 — SOU EXTENSION 4 GRANTED
- 27 Jan 2025 — SOU EXTENSION 4 FILED
- 25 Apr 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 27 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 20 Nov 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 24 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Jul 2024 — SOU EXTENSION 3 GRANTED
- 22 Jul 2024 — SOU EXTENSION 3 FILED
- 22 Jul 2024 — SOU TEAS EXTENSION RECEIVED
- 23 Dec 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Dec 2023 — SOU EXTENSION 2 GRANTED
- 21 Dec 2023 — SOU EXTENSION 2 FILED